Intracellular Regulation of the Metabolism of Arachidonic Acid in Human Platelets^[*]

• 

^* Invited Symposium V “Platelets: Intravascular Control Mechanisms” presented to VIth International Congress on Thrombosis and Haemostasis, philadelphia, U. S. A. June 1977

• References

• 1 Bills TK, Smith JB, Silver MJ. 1976; Metabolism of¹⁴C-arachidonic acid by human platelets. Biochimica et Biophysica Acta 424: 303
• 2 Bills TK, Smith JB, Silver MJ. 1977; Selective release of arachidonic acid from the phospholipids of human platelets in response to thrombin. Journal of Clinical Investigation 60: 1
• 3 Bunting S, Gryglewski R, Moncada S, Vane JR. 1976; Arterial walls generate from prostaglandin endoperoxides a substance (Prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 12: 897
• 4 Chiappe De Cingolani GE, Van Den Bosch H, Van Deenen LL M. 1972; Phospholipase A and lysophospholipase activities in isolated fat cells: effect of cyclic 3’, 5’-AMP. Biochimica et Biophysica Acta 260: 387
• 5 Derksen A, Cohen P. 1975; Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. Journal of Biological Chemistry 250: 9342
• 6 Gerrard JM, Peller JD, Krick TP, White JG. 1977; Cyclic AMP and platelet prostaglandin synthesis. Prostaglandins 14: 39
• 7 Gorman RR, Bunting S, Miller OV. 1977; Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377
• 8 Hagenfeldt L, Wahren J. 1975; Turnover of plasma free arachidonic and oleic acids in resting and exercising human subjects. Metabolism 24: 799
• 9 Hamberg M, Samuelsson B. 1973; Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 70: 899
• 10 Hamberg M, Samuelsson B. 1974; Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets Proceedings of the National Academy of Sciences of the United States of America 71: 3400
• 11 Hamberg M, Svensson J, Samuelsson B. 1975; Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Sciences of the United States of America 72: 2994
• 12 Iacono JM, Zellner DC, Paoletti R, Ishikawa I, Frigeni V, Eumagelli R. 1973; Comparison of blood platelet and erythrocyte lipids in man in three age groups from three regions: Milan, Cinncinati and Sicily. Haemostasis 2: 141
• 13 Lands WE M, Letellier PR, Rome LH, Vanderhoek JY. 1973; Inhibition of prostaglandin biosynthesis. Advances in Bioscience 9 Suppl 15
• 14 Marcus AJ, Ullman HL, Safier LB. 1969; Lipid composition of subcellular particles of human blood platelets. Journal of Lipid Research 10: 108
• 15 Minkes M, Stanford N, Chi MY, Roth JG, Raz A, Needleman P, Majerus PW. 1977; Cyclic adenosine 3’,5’-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. Journal of Clinical Investigation 59: 449
• 16 Nugteren DH, Hazelhof E. 1973; Isolation and properties of intermediates in prostaglandin biosynthesis. Biochimica et Biophysica Acta 326: 448
• 17 Pace-Asciak C, Wolfe LS. 1968; Inhibition of prostaglandin synthesis by oleic, linoleic and linolenic acids. Biochimica et Biophysica Acta 152: 784
• 18 Pickett WC, Jesse RL, Cohen P. 1977; Initiation of phospholipase A₂activity in human platelets by the calcium ion ionophore A23187. Biochimica et Biophysica Acta 486: 209
• 19 Silver MJ, Smith JB, Ingerman C, Kocsis JJ. 1973; Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins 4: 863
• 20 Smith JB, Ingerman CM, Kocsis JJ, Silver MJ. 1973; Formation of prostaglandins during the aggregation of human blood platelets. Journal of Clinical Investigation 52: 965
• 21 Tateson JE, Moncada S, Vane JR. 1977; Effects of prostacyclin (PGX) on cyclic AMP concentrations of human platelets. Prostaglandins 13: 389